Yadagiri Pendri

Statistics

Publications

Citations

261

H-Index

Active since

2002

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Yadagiri Pendri is an author at Bristol-Myers Squibb (United States) specializing in medicinal chemistry, pharmacy, and synthetic medicinal chemistry.

Publications per year

2002–2012

Publications

The synthesis and characterization of BMS-204352 (MaxiPost™) and related 3-fluorooxindoles as openers of maxi-K potassium channels

Piyasena Hewawasam, Valentin K. Gribkoff, Yadagiri Pendri et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 184 citations

Pharmacy, Medicinal Chemistry, Pharmacology +10

Preparation of a chiral synthon for an HBV inhibitor: enzymatic asymmetric hydrolysis of (1α,2β,3α)-2-(benzyloxymethyl)cyclopent-4-ene-1,3-diol diacetate and enzymatic asymmetric acetylation of (1α,2β,3α)-2-(benzyloxymethyl)cyclopent-4-ene-1,3-diol

Ramesh N. Patel, Amit Banerjee, Yadagiri Pendri et al. · Tetrahedron Asymmetry · 2006 · 22 citations

Life Sciences, Biochemistry, Medicinal Chemistry +14

An Improved Synthesis of a Selective Serotonin Reuptake Inhibitor

Robert Anthes, Serge Benoit, Chien‐Kuang Chen et al. · Organic Process Research & Development · 2008 · 20 citations

Pharmacy, Chemistry, Medicinal Chemistry +13

Selection of an Enantioselective Process for the Preparation of a CGRP Receptor Inhibitor

Reginald O. Cann, Chung-Pin H. Chen, Qi Gao et al. · Organic Process Research & Development · 2012 · 20 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13

Development of an Efficient and Scalable Process of a Respiratory Syncytial Virus Inhibitor

David P. Provencal, Kirsten D. Gesenberg, Hua Wang et al. · Organic Process Research & Development · 2004 · 15 citations

Pharmacy, Infectious Diseases, Medicinal Chemistry +11

1–5 of 5